February 27, 2015 7:10 AM ET

Biotechnology

Company Overview of ZetaRx Biosciences, Inc.

Company Overview

ZetaRx Biosciences, Inc., a biotechnology company, develops therapies using genetically engineered lymphocites for the treatment of cancers and other diseases. The company was formerly known as ZetaRX LLC. ZetaRx Biosciences, Inc. was founded in 2008 and is based in Seattle, Washington. As of September 30, 2013, ZetaRx Biosciences, Inc. operates as a subsidiary of Juno Therapeutics Inc.

307 Westlake Avenue North

Suite 300

Seattle, WA 98109

United States

Founded in 2008

Phone:

206-262-5696

Key Executives for ZetaRx Biosciences, Inc.

ZetaRx Biosciences, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Natural Industries, Inc. United States
Apsara Medical Corporation United States
Harkness Pharmaceuticals, Inc. United States
KMS Industries, Inc. United States
PharmSelex United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 12, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZetaRx Biosciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.